Volume 4, Special Edition 2: Special Edition: Issue 2

 e-Cystic Fibrosis Review is a monthly CE series for nurses, nurse practitioners, and others involved in the care of patients with Cystic Fibrosis. It provides updates on the latest research, best practices, and issues currently under debate, as well as a concise review of relevant journal literature.

(Volume 4, Special Edition 2 )

Target Audience

Nurses and health care professionals involved in the care of patients with Cystic Fibrosis.

Learning Objectives

After participating in this activity, the participant will demonstrate the ability to:    

  • Describe the effects and safe dosage of nitric oxide (NO) for cystic fibrosis (CF) pathogen reduction
  • Identify risk factors for Non-tuberculous mycobacteria (NTM) infection
  • Understand the relationship between alpha-1-antitrypsin/ neutrophil elastase (AAT/NE) and CF disease
  • Discuss bronchoscopy as an alternative to cough swabs for detecting lower lung infections
  • Explain the positive effects of VX-809 combined with ivacaftor on patients with the F508del CFTR mutation
 
Additional information
Contact email: 
Course summary
Available credit: 
  • 1.00 ANCC
Course opens: 
09/26/2013
Course expires: 
09/25/2015
Cost:
$0.00

Margaret Rosenfeld, MD, MPH

Professor

Division of Pulmonary Medicine

Seattle Children’s Hospital and Department of Pediatrics

University of Washington School of Medicine

Seattle, Washington

Available Credit

  • 1.00 ANCC

Accreditation Period

Course opens: 
09/26/2013
Course expires: 
09/25/2015

Price

Cost:
$0.00
Please login or register to take this course.

Required Hardware/software

Make sure your Adobe flash is updated by clicking HERE